Loading clinical trials...

COMPLETEDPhase 2NCT00559091

A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia

The purpose of this study is to determine if ribavirin (a drug commonly used to treat hepatitis C) also has activity in the treatment of patients with refractory or relapsed acute myeloid leukemia (AM...

Lead sponsor: Jewish General Hospital•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

Experimental Bone Marrow Transplant Protocol

NCT00061581 · Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, and more

COMPLETEDPhase 1

Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)

NCT00854646 · Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, and more

TERMINATEDPhase 1

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

NCT02255162 · Acute Myeloid Leukemia (AML), Acute Myelocytic Leukemia, and more

UNKNOWNPhase 3

Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia

NCT02244658 · Antineoplastic Adverse Reaction, Thrombocytopenia, and more

COMPLETEDPhase 3

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

NCT01188798 · Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 22, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment18

Start dateApr 2007

Last updatedDec 22, 2022

Condition

Acute Myelocytic Leukemia

Locations shown

McMaster Hospital

Hamilton, Ontario

Maisonneuve-Rosemont Hospital

Montreal, Quebec

Jewish General Hospital

Montreal, Quebec

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 22, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions